stavudine has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Apalata, T; Bam, NE; Chitha, W; Mabunda, SA; Nomatshila, SC; Ntsaba, J | 1 |
Dehayem, MY; Echouffo-Tcheugui, JB; Ekali, LG; Fezeu, L; Hayes, L; Johnstone, LK; Kouanfack, C; Nouthe, B; Sobngwi, E; Unwin, NC | 1 |
Brambilla, AM; Calori, G; Castagna, A; Lazzarin, A; Luzi, L; Meneghini, E; Novati, R; Vacchini, D | 1 |
1 trial(s) available for stavudine and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
The association between HIV tri-therapy with the development of Type-2 Diabetes Mellitus in a rural South African District: A case-control study.
Topics: Adult; Diabetes Mellitus, Type 2; Female; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Rural Population; South Africa; Stavudine; Time Factors; Zidovudine | 2020 |
2 other study(ies) available for stavudine and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood Glucose; Blood Pressure; Body Fat Distribution; Cameroon; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Health Services Accessibility; HIV Infections; Humans; Insulin Resistance; Lipids; Male; Stavudine; Time Factors | 2013 |
Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-HIV Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Indinavir; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine | 2003 |